Ingeniatrics at the TV programme "Espacio Empresa"
About Ingeniatrics
Friday, 14 June 2013 09:38

On Saturday June 8 was broadcasted in TVE 2, at the programme "Espacio Empresa", a report dedicated to reviewing Ingeniatrics business development, as well as the achievements made so far and future projects.

Ingeniatrics has established itself as a leading company in micro-encapsulation technologies, offering services tailored to the needs of its client in a wide range of business sectors, ranging from agri-food, to the pharmaceutical, environmental, biotechnological or health care industry, among others.

To watch the video click here

Ingeniatrics receives a new investment
About Ingeniatrics
Thursday, 06 June 2013 00:00

After the initial investment approved in early 2011, Ingeniatrics receives a new injection of capital to guarantee scaling success and move forward from laboratory to the pre-industrial scale processes, and thereby to carry out our definitive industrial scale expansion and development of our Flow Focusing ® Microencapsulation plant scaling.

With the aim of positioning Ingeniatrics as a leading company in the development of microfluidic technology and associated technologies for Pharma, Biotech and Fine Chemicals, the Jeremie venture capital fund, managed by Invercaria SGCR; Caixa Capital Risc, La Caixa's Private Equity subsidiary and the Reference Shareholders have made a second fund-raising. They have become to rely on our project and give us a push over to the achievement of our goals.

Ingeniatrics has validated its Flow Focusing technology with several world-class leading companies, going from companies in the area of consumer goods, to pharmaceuticals, biotechnology industry and fine chemicals.

Quality and Environmental Audit
About Ingeniatrics
Wednesday, 15 May 2013 00:00

On February 14th took place in Ingeniatrics the first Follow-up Quality and Environmental Systems Audit, implanted in our company in March 2012. Upon completion, we are pleased to inform you that the result has been "Compliance Evaluation", detecting only some minor non-conformities that are already solved.

The good result obtained is mainly due to all our daily efforts in matching products to the customers´ expectations, taking into account both their demands and the market specifications, as well as our staff suggestions. We provide the necessary human and material resources for achieving the goals marked at all times.

Equally, Ingeniatrics have a firm commitment with preventing or, where the case, minimizing environmental pollution, promoting the reduction and recycling of materials whenever possible. We take all necessary protective measures to prevent accidental releases to the environment, incluidng leaks and spills of machinery and equipment. We make sure to promote environmental awareness and training of each member of the company, as well as contractors, through continuous training to ensure that all the work is performed in a way that respects the environment. For that we use the best a available technologies that allow us to reduce the environmental impacts of our business.
Ingeniatrics takes part in technological project SCALEPROT
About Ingeniatrics
Monday, 08 April 2013 00:00

The therapeutic recombinant protein production has changed the way we see modern medicine, contributing to the creation of innovative and effective therapies against chronic diseases, with emphasis on neoplasics and degenerative diseases. Therefore, in recent years, the use of therapeutic peptides and proteins in human and veterinary medicine have increased sharply; actually the 50% of the new molecules approved by the FDA for clinical research have a biotechnological origin. The global market of biopharmaceuticals for human use has now reached 30,000 million dollars and is expected to double in the coming years.

SCALEPROT was born with the prospect of covering a high demand market. The aim of the project was the research and development of new ways of scaling preindustrial exclusive innovative technologies coming from companies such as Ingeniatrics, Biomedal, Bionaturis and Infarmade, in order to train them in the production and development of therapeutic recombinant proteins under quality standards.

This way it has been successfully achieved the increase of the capacity of the mentioned companies to offer products and services CRO and CMO of a higher value for the biopharmaceutical industry, including the possibility of offering more integrated services from some of the participating companies. It was also intended to develop technologies for production, formulation and analysis of candidate molecules to be used in the pharmaceutical industry as well as purification systems, or as candidate therapeutic molecules to pass clinical phase.

Ingeniatrics en el "Bio Europe Spring" de Barcelona
About Ingeniatrics
Wednesday, 20 March 2013 00:00

From 11 to 13th March, Barcelona hosted the annual Bio Europe Spring which takes place in a different European city each year. Over 2000 attendees and more than 1200 international companies from the cosmetic, pharma and biotech fields were represented. Ingeniatrics´ CEO Agustin Mariscal, and the Marketing Manager Miriam Goldberg, represented the company at the event.

The main objective of the Bio Spring was to bring together suppliers and technology claimant companies, leading in the biotechnology sector. According to Miriam Goldberg, “our experience with EBD group fairs has always been exceptional.  Those conferences have an extraordinary business potential due to the given opportunity to participate in intense on-to-one meetings. They also allow the participants to establish strategic partners and to get into new business opportunities, mainly with pharmacy companies.”

Ingeniatrics keeps its position in the ranking of the Top 10 companies in IP portfolio amplification
About Ingeniatrics
Thursday, 20 December 2012 12:50

Due to the licensing agreement between Ingeniatrics and the University of Seville, the Andalusian biotechnology company increased its number of patents and placed as the sixth Spanish bank as first applicant.

Crisis plus technology plus innovation are the perfect resource to keep walking in order to overcome the current enterprises difficulties.

To see the full report click here

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 2 of 20